Evidence · Education · Clinical reasoning
Explore clinician learning resources covering formulation philosophy, the endocannabinoid system, treatment planning and product formats. Start with the scientific framework, then continue to the relevant clinical resources. Product-specific materials require verified clinician access on the live website.
A practical overview for Australian doctors covering assessment, SAS-B and Authorised Prescriber pathways, product categories, consent and follow-up.
Read resourceUnderstand Australian medicinal cannabis growth figures, the difference between approvals and patients, and how to interpret SAS and AP data.
Read resourceExplore Australian medicinal cannabis access, oral and inhaled product formats, clinical selection factors and the limits of market statistics.
Read resourceExplore a proposed foundation and advanced learning structure covering pharmacology, patient selection, access pathways, safety and clinical governance.
Read resourceUnderstand Australian paediatric medicinal cannabis access, specialist involvement, evidence boundaries, consent and monitoring considerations.
Read resourceExplore a five-layer formulation model: cannabinoids, targeted ingredients, terpenes, recovery components and delivery. Read the evidence limits.
Read resourceUnderstand how sleep, pain, stress and interacting body systems inform a multi-pathway formulation model, with practical questions for clinical review.
Read resourceRead a clinician-focused framework covering presentation, route, cannabinoid exposure, adjunct evidence, interactions and outcome monitoring.
Read resourceExplore the scientific rationale for considering cannabinoid therapy within wider neurological, immune, metabolic and behavioural care.
Read resourceUnderstand foundation, daytime, night and breakthrough treatment roles, with assessment, monitoring and review principles for prescribers.
Read resourceUnderstand the intended foundation, daytime and night treatment roles behind BASE, FLOW and RESET in a structured clinical framework.
Read resourceClinician resource covering oral formulation design, cannabinoid concentrations, supporting ingredients, dose interpretation and review.
Read resourceClinician resource on inhaled formats, prior THC exposure, patient selection, impairment, adverse effects and treatment review.
Read resourceClinician reference on medicinal cannabis oils, formulation differences, product specifications and clinical assessment considerations.
Read resourceClinician reference on medicinal cannabis gummies, formulation differences, product specifications and clinical assessment considerations.
Read resourceClinician reference on medicinal cannabis flower, formulation differences, product specifications and clinical assessment considerations.
Read resourceClinician reference on medicinal cannabis vapes, formulation differences, product specifications and clinical assessment considerations.
Read resource